Treatment of Acute Ischemic Stroke With Rt-PA Combined With Edaravone Dexborneol
A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 400 participants.
Also called NCT06248242
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; double masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 400 participants
- Registry
-
NCT06248242
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- China
- Registry status
- Unknown status
Technical summary
Registry record NCT06248242. Randomized; double masking; primary purpose treatment. Start 2021-06-01 (actual); primary completion 2024-06-30 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Treatment of Acute Ischemic Stroke With Rt-PA Combined With Edaravone Dexborneol
- Acronym
- TASPE
- Condition
- Acute Ischemic Stroke
- Intervention (Drug)
- Edaravone dexborneol
- Lead sponsor
- The Second Hospital of Hebei Medical University
Record details
- Record id
cardio:ct-nct06248242- Content hash
c5230e3210b0c2956e8f5cadf372cab99c426032068802b701e351519a9ce083